ECHELON BIOSCIENCES, INC.

Basic Information

675 Arapeen Drive, Suite 302
Salt Lake City, UT, 84108-1228

Company Profile

n/a

Additional Details

Field Value
DUNS: 179151188
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: n/a


  1. Targeting ether lipid biosynthesis for disease

    Amount: $224,334.00

    DESCRIPTION (provided by applicant): Cancer is a significant health burden in the US and across the globe, representing the second leading cause of death in the US. Cancer cells have metabolic pathway ...

    SBIR Phase I 2014 Department of Health and Human Services
  2. IGF::OT::IGF-- Biomarkers for Alcohol and ALD

    Amount: $625,360.00

    This contract addresses the need for reliable and accurate biomarkers of alcohol consumption, initially in response to a National Institute on Alcohol Abuse and Alcoholism (NIAAA)-initiated Small Busi ...

    SBIR Phase II 2014 Department of Health and Human Services
  3. SBIR Phase II: Near Infrared Substrates for Imaging Autotaxin Activity In Vivo

    Amount: $487,812.00

    This Small Business Innovation Research (SBIR) Phase II project aims to further develop ATX-Red, an in vivo imaging agent that becomes fluorescent in the presence of the enzyme autotaxin. Autotaxin an ...

    SBIR Phase II 2012 National Science Foundation
  4. SBIR PHASE II- 1,136,508YR 1: BASE: 548,090, PARTIALLY FUNDED AT 430,000 (BALANCE TO BE FUNDED: 118,090)YR 2: OPTION: 588,418

    Amount: $548,090.00

    There needs to better biomarkers of alcohol consumption and alcohol induced organ damage. PEth is a nonoxidative, long-lasting metabolite of ethanol consumption and alcohol related organ damage. PEth ...

    SBIR Phase II 2012 Department of Health and Human Services
  5. New Approach to Phospholipidosis Prediction

    Amount: $149,884.00

    DESCRIPTION (provided by applicant): Drug safety is a major concern for people that taking medicines as well as pharmaceutical companies, regulatory bodies, and basic researchers. Drug induced phospho ...

    SBIR Phase I 2011 Department of Health and Human Services
  6. SBIR Phase I: Near Infrared Substrates for Imaging Autotaxin Activity In Vivo

    Amount: $150,000.00

    This Small Business Innovation Research (SBIR) Phase I project aims to synthesize ATXRed, an in vivo imaging agent that is specifically activated by the enzymatic activity of autotaxin. Autotaxin is a ...

    SBIR Phase I 2010 National Science Foundation
  7. Anti-Phospholipid Multiplex For Pathologic Epitopes

    Amount: $248,864.00

    DESCRIPTION (provided by applicant): This project will help delineate the true nature of antigens in antiphospholipid syndrome (APS). Application of this knowledge would accelerate the pace of basic a ...

    SBIR Phase I 2010 Department of Health and Human Services
  8. Aptamer-based Glycomics Tools

    Amount: $277,549.00

    DESCRIPTION (provided by applicant): Protein glycosylation plays very important roles in biological processes. However, detecting and differentiating such modifications rapidly is not a trivial issue. ...

    STTR Phase II 2010 Department of Health and Human Services
  9. Aptamer-based Glycomics Tools

    Amount: $277,549.00

    DESCRIPTION (provided by applicant): Protein glycosylation plays very important roles in biological processes. However, detecting and differentiating such modifications rapidly is not a trivial issue. ...

    STTR Phase I 2009 Department of Health and Human Services
  10. Methylerythritol Phosphate Pathway-Specific Natural Products as Antibacterials

    Amount: $592,461.00

    DESCRIPTION (provided by applicant): The long-term objective of this project is to identify a new class of antibiotics targeting the methylerythritol phosphate (MEP) pathway, a novel pathway essential ...

    SBIR Phase I 2008 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government